FENNEC PHARMACEUTICALS INC.
FENC · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Sayad Pierre Sargis: Form 4
Insider disclosure · Filed · Report period 12 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- FENC · 31447P100 - Common Shares, no par value
Company details and SEC sources
CIK 0001211583 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- FENC on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC, 27709
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- 31 December
- Former names on EDGAR
- ADHEREX TECHNOLOGIES INC (to 14 Aug 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields